- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.40 Å
- Oligo State
- hetero-3-3-3-mer
- Ligands
- 60 x GOL: GLYCEROL(Non-functional Binders)
- 6 x MN: MANGANESE (II) ION(Non-covalent)
MN.14: 9 residues within 4Å:- Chain A: H.99, W.120, D.122, H.124, D.126, D.230, E.275
- Ligands: MN.15, SO4.22
4 PLIP interactions:4 interactions with chain A- Metal complexes: A:H.99, A:D.122, A:D.126, A:D.230
MN.15: 7 residues within 4Å:- Chain A: D.122, A.123, H.124, D.230, D.232
- Ligands: MN.14, SO4.22
5 PLIP interactions:5 interactions with chain A- Metal complexes: A:D.122, A:H.124, A:D.230, A:D.232, A:D.232
MN.53: 9 residues within 4Å:- Chain D: H.99, W.120, D.122, H.124, D.126, D.230, E.275
- Ligands: MN.54, SO4.61
4 PLIP interactions:4 interactions with chain D- Metal complexes: D:H.99, D:D.122, D:D.126, D:D.230
MN.54: 7 residues within 4Å:- Chain D: D.122, A.123, H.124, D.230, D.232
- Ligands: MN.53, SO4.61
5 PLIP interactions:5 interactions with chain D- Metal complexes: D:D.122, D:H.124, D:D.230, D:D.232, D:D.232
MN.92: 9 residues within 4Å:- Chain G: H.99, W.120, D.122, H.124, D.126, D.230, E.275
- Ligands: MN.93, SO4.100
4 PLIP interactions:4 interactions with chain G- Metal complexes: G:H.99, G:D.122, G:D.126, G:D.230
MN.93: 7 residues within 4Å:- Chain G: D.122, A.123, H.124, D.230, D.232
- Ligands: MN.92, SO4.100
5 PLIP interactions:5 interactions with chain G- Metal complexes: G:D.122, G:H.124, G:D.230, G:D.232, G:D.232
- 51 x SO4: SULFATE ION(Non-functional Binders)
SO4.16: 2 residues within 4Å:- Chain A: R.199, R.203
Ligand excluded by PLIPSO4.17: 5 residues within 4Å:- Chain A: P.56, N.67, P.68, R.69, P.158
Ligand excluded by PLIPSO4.18: 2 residues within 4Å:- Chain A: K.17, R.18
Ligand excluded by PLIPSO4.19: 5 residues within 4Å:- Chain A: L.157, P.158, G.159, F.160, S.161
Ligand excluded by PLIPSO4.20: 2 residues within 4Å:- Chain A: R.221, Q.222
Ligand excluded by PLIPSO4.21: 3 residues within 4Å:- Chain A: R.203, L.204, R.212
Ligand excluded by PLIPSO4.22: 11 residues within 4Å:- Chain A: H.99, D.122, H.124, D.126, H.139, D.230, D.232, T.244, E.275
- Ligands: MN.14, MN.15
Ligand excluded by PLIPSO4.23: 3 residues within 4Å:- Chain A: L.44, K.45, D.46
Ligand excluded by PLIPSO4.24: 3 residues within 4Å:- Chain A: H.185, K.189
- Chain G: G.309
Ligand excluded by PLIPSO4.28: 4 residues within 4Å:- Chain B: K.80
- Chain F: P.64, R.66, Q.84
Ligand excluded by PLIPSO4.29: 4 residues within 4Å:- Chain B: G.117, T.118, L.119
- Ligands: GOL.26
Ligand excluded by PLIPSO4.34: 4 residues within 4Å:- Chain C: K.71, S.72, G.73
- Ligands: GOL.31
Ligand excluded by PLIPSO4.35: 3 residues within 4Å:- Chain C: S.57, E.58, R.59
Ligand excluded by PLIPSO4.36: 2 residues within 4Å:- Chain C: A.165, G.166
Ligand excluded by PLIPSO4.37: 2 residues within 4Å:- Chain C: R.197, S.198
Ligand excluded by PLIPSO4.38: 3 residues within 4Å:- Chain B: R.116
- Chain C: T.47, A.48
Ligand excluded by PLIPSO4.39: 3 residues within 4Å:- Chain C: S.29, S.30, T.74
Ligand excluded by PLIPSO4.55: 2 residues within 4Å:- Chain D: R.199, R.203
Ligand excluded by PLIPSO4.56: 5 residues within 4Å:- Chain D: P.56, N.67, P.68, R.69, P.158
Ligand excluded by PLIPSO4.57: 2 residues within 4Å:- Chain D: K.17, R.18
Ligand excluded by PLIPSO4.58: 5 residues within 4Å:- Chain D: L.157, P.158, G.159, F.160, S.161
Ligand excluded by PLIPSO4.59: 2 residues within 4Å:- Chain D: R.221, Q.222
Ligand excluded by PLIPSO4.60: 3 residues within 4Å:- Chain D: R.203, L.204, R.212
Ligand excluded by PLIPSO4.61: 11 residues within 4Å:- Chain D: H.99, D.122, H.124, D.126, H.139, D.230, D.232, T.244, E.275
- Ligands: MN.53, MN.54
Ligand excluded by PLIPSO4.62: 3 residues within 4Å:- Chain D: L.44, K.45, D.46
Ligand excluded by PLIPSO4.63: 3 residues within 4Å:- Chain A: G.309
- Chain D: H.185, K.189
Ligand excluded by PLIPSO4.67: 4 residues within 4Å:- Chain E: K.80
- Chain I: P.64, R.66, Q.84
Ligand excluded by PLIPSO4.68: 4 residues within 4Å:- Chain E: G.117, T.118, L.119
- Ligands: GOL.65
Ligand excluded by PLIPSO4.73: 4 residues within 4Å:- Chain F: K.71, S.72, G.73
- Ligands: GOL.70
Ligand excluded by PLIPSO4.74: 3 residues within 4Å:- Chain F: S.57, E.58, R.59
Ligand excluded by PLIPSO4.75: 2 residues within 4Å:- Chain F: A.165, G.166
Ligand excluded by PLIPSO4.76: 2 residues within 4Å:- Chain F: R.197, S.198
Ligand excluded by PLIPSO4.77: 3 residues within 4Å:- Chain E: R.116
- Chain F: T.47, A.48
Ligand excluded by PLIPSO4.78: 3 residues within 4Å:- Chain F: S.29, S.30, T.74
Ligand excluded by PLIPSO4.94: 2 residues within 4Å:- Chain G: R.199, R.203
Ligand excluded by PLIPSO4.95: 5 residues within 4Å:- Chain G: P.56, N.67, P.68, R.69, P.158
Ligand excluded by PLIPSO4.96: 2 residues within 4Å:- Chain G: K.17, R.18
Ligand excluded by PLIPSO4.97: 5 residues within 4Å:- Chain G: L.157, P.158, G.159, F.160, S.161
Ligand excluded by PLIPSO4.98: 2 residues within 4Å:- Chain G: R.221, Q.222
Ligand excluded by PLIPSO4.99: 3 residues within 4Å:- Chain G: R.203, L.204, R.212
Ligand excluded by PLIPSO4.100: 11 residues within 4Å:- Chain G: H.99, D.122, H.124, D.126, H.139, D.230, D.232, T.244, E.275
- Ligands: MN.92, MN.93
Ligand excluded by PLIPSO4.101: 3 residues within 4Å:- Chain G: L.44, K.45, D.46
Ligand excluded by PLIPSO4.102: 3 residues within 4Å:- Chain D: G.309
- Chain G: H.185, K.189
Ligand excluded by PLIPSO4.106: 4 residues within 4Å:- Chain C: P.64, R.66, Q.84
- Chain H: K.80
Ligand excluded by PLIPSO4.107: 4 residues within 4Å:- Chain H: G.117, T.118, L.119
- Ligands: GOL.104
Ligand excluded by PLIPSO4.112: 4 residues within 4Å:- Chain I: K.71, S.72, G.73
- Ligands: GOL.109
Ligand excluded by PLIPSO4.113: 3 residues within 4Å:- Chain I: S.57, E.58, R.59
Ligand excluded by PLIPSO4.114: 2 residues within 4Å:- Chain I: A.165, G.166
Ligand excluded by PLIPSO4.115: 2 residues within 4Å:- Chain I: R.197, S.198
Ligand excluded by PLIPSO4.116: 3 residues within 4Å:- Chain H: R.116
- Chain I: T.47, A.48
Ligand excluded by PLIPSO4.117: 3 residues within 4Å:- Chain I: S.29, S.30, T.74
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Austin, M. et al., Structural and functional characterization of C0021158, a high-affinity monoclonal antibody that inhibits Arginase 2 function via a novel non-competitive mechanism of action. Mabs
- Release Date
- 2020-06-10
- Peptides
- Arginase-2, mitochondrial: ADG
Fab C0021158 heavy chain (IgG1): BEH
Fab C0021158 light chain (IgG1): CFI - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AAAD
AAAG
AAAB
HHHE
HHHH
HHHC
LLLF
LLLI
LLL
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.40 Å
- Oligo State
- hetero-3-3-3-mer
- Ligands
- 60 x GOL: GLYCEROL(Non-functional Binders)
- 6 x MN: MANGANESE (II) ION(Non-covalent)
- 51 x SO4: SULFATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Austin, M. et al., Structural and functional characterization of C0021158, a high-affinity monoclonal antibody that inhibits Arginase 2 function via a novel non-competitive mechanism of action. Mabs
- Release Date
- 2020-06-10
- Peptides
- Arginase-2, mitochondrial: ADG
Fab C0021158 heavy chain (IgG1): BEH
Fab C0021158 light chain (IgG1): CFI - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AAAD
AAAG
AAAB
HHHE
HHHH
HHHC
LLLF
LLLI
LLL